BridgeMD
New treatment option for Parastomal Hernia
Official title Laparoscopic Total Extraperitoneal Plasty as a Modification of Sugabecker's Operation
ClinicalTrials.gov ID: NCT06474403
What this study is testing
- What it's testing
- Abstract: Parastomal hernia is a frequent complication following stoma formation, presenting a significant surgical challenge with high recurrence rates. The present study explores the efficacy of the laparoscopic total extraperitoneal (TEP) approach in parastomal hernia repair, conceived as a modification of the Sugabecker's operation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients with a confirmed diagnosis of parastomal hernia post-stoma creation surgery;
- Symptomatic hernias requiring surgical intervention;
- Able to undergo the surgical approach under general anesthesia;
- Patients who can provide informed consent. Non- Patients with contraindications to laparoscopic surgery, such as uncontrolled coagulopathies, severe...
You likely can't join if
- Patients unwilling to provide informed consent;
- Patients with a life expectancy less than the study follow-up period;
- Patients who have previously undergone other types of hernia repair, which could confound the operative and postoperative outcomes being measured.
The study team makes the final eligibility decision.
Where it's taking place
- Krasnodar, Russia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Krasnodar, Russia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.